ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) reached a new 52-week low during trading on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $29.00 to $25.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. ACADIA Pharmaceuticals traded as low as $17.56 and last traded […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) reached a new 52-week low during trading on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $29.00 to $25.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. ACADIA Pharmaceuticals traded as low as $17.56 and last traded […]
ASLAN Pharmaceuticals (NASDAQ:ASLN – Get Free Report) is scheduled to be releasing its earnings data on Monday, March 25th. ASLAN Pharmaceuticals Stock Performance Shares of NASDAQ ASLN opened at $0.65 on Friday. ASLAN Pharmaceuticals has a 1 year low of $0.39 and a 1 year high of $4.69. The company has a current ratio of […]
Schonfeld Strategic Advisors LLC lowered its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 36.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,800 shares of the specialty pharmaceutical company’s stock after selling 18,200 shares during the quarter. Schonfeld […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2023 earnings estimates for shares of ORIC Pharmaceuticals in a note issued to investors on Monday, February 26th. Cantor Fitzgerald analyst P. Agrawal anticipates that the company will post earnings per share of ($1.90) for the year. Cantor Fitzgerald has […]